A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

Clinical trial NCT00152386 · COMPLETED

Trial details

NCT number: NCT00152386
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2005-02-01
Primary completion: 2006-10-01
Enrollment: 950

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.